Motus GI back on NASDAQ

Medical endoscopy solutions company Motus GI received formal notice that it can once again trade on the NASDAQ stock market after falling below the minimum bid price requirement earlier this year, according to an Aug. 11 news release.

Advertisement

Motus GI joined the stock market in early 2018 and fell below the minimum bid price requirement in early 2022, according to a Feb. 24 news release. 

On Aug. 9, the company was able to list and trade stock on the market again after its ordinary shares reached a closing bid price at or greater than $1 per share for 10 consecutive business days.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.